Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

305 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Phase III study comparing a semimonthly with a monthly regimen of fluorouracil and leucovorin as adjuvant treatment for stage II and III colon cancer patients: final results of GERCOR C96.1.
André T, Quinaux E, Louvet C, Colin P, Gamelin E, Bouche O, Achille E, Piedbois P, Tubiana-Mathieu N, Boutan-Laroze A, Flesch M, Lledo G, Raoul Y, Debrix I, Buyse M, de Gramont A. André T, et al. Among authors: louvet c. J Clin Oncol. 2007 Aug 20;25(24):3732-8. doi: 10.1200/JCO.2007.12.2234. J Clin Oncol. 2007. PMID: 17704423 Clinical Trial.
Semimonthly versus monthly regimen of fluorouracil and leucovorin administered for 24 or 36 weeks as adjuvant therapy in stage II and III colon cancer: results of a randomized trial.
Andre T, Colin P, Louvet C, Gamelin E, Bouche O, Achille E, Colbert N, Boaziz C, Piedbois P, Tubiana-Mathieu N, Boutan-Laroze A, Flesch M, Buyse M, de Gramont A. Andre T, et al. Among authors: louvet c. J Clin Oncol. 2003 Aug 1;21(15):2896-903. doi: 10.1200/JCO.2003.10.065. J Clin Oncol. 2003. PMID: 12885807 Clinical Trial.
Colorectal cancer: integrating oxaliplatin.
Louvet C, de Gramont A. Louvet C, et al. Curr Treat Options Oncol. 2003 Oct;4(5):405-11. doi: 10.1007/s11864-003-0041-8. Curr Treat Options Oncol. 2003. PMID: 12941200 Review.
FOLFIRI followed by FOLFOX6 or the reverse sequence in advanced colorectal cancer: a randomized GERCOR study.
Tournigand C, André T, Achille E, Lledo G, Flesh M, Mery-Mignard D, Quinaux E, Couteau C, Buyse M, Ganem G, Landi B, Colin P, Louvet C, de Gramont A. Tournigand C, et al. Among authors: louvet c. J Clin Oncol. 2004 Jan 15;22(2):229-37. doi: 10.1200/JCO.2004.05.113. Epub 2003 Dec 2. J Clin Oncol. 2004. PMID: 14657227 Corrected and republished. Clinical Trial.
305 results